Related Experiment Videos
Experiences of People With Poorly Controlled Type 2 Diabetes Using Telemonitoring: Qualitative Study Embedded in a
Iben Engelbrecht Giese1, Sisse Heiden Laursen1,2,3, Pernille Frøstrup Barington2
1Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Selma Lagerløfs Vej 249, Gistrup, North Denmark, 9260, Denmark, 45 99409940.
JMIR Formative Research
|May 28, 2026
Summary
Telemonitoring improves type 2 diabetes management, with patient feedback enhancing usability. Integrating user preferences and improving device design are key for future interventions.
Area of Science:
- Digital Health
- Diabetes Management
- Patient-Centered Care
Background:
- Telemonitoring shows promise for improving glycemic control in type 2 diabetes.
- Optimal integration of self-management education within telemonitoring requires further investigation.
- Patient feedback is crucial for enhancing the usability, engagement, and real-world effectiveness of such interventions.
Purpose of the Study:
- To explore patient experiences and acceptability of two distinct telemonitoring intervention designs.
- To assess trial procedures within a feasibility study for non-insulin-dependent type 2 diabetes.
- To gather insights for optimizing future telemonitoring interventions.
Main Methods:
- Qualitative research design utilizing semistructured interviews.
- Thematic analysis based on Braun and Clarke's approach.
- Interviews conducted with 12 participants post-telemonitoring intervention.
Main Results:
- Participants found telemonitoring devices, especially for blood glucose, easy to use and informative.
- Technical issues were noted with activity trackers and initial setup; measurement schedules varied in perceived flexibility.
- Strong value placed on continuous communication with healthcare professionals, fostering trust and enhancing diabetes understanding.
- Increased insight into lifestyle-blood glucose relationships motivated healthier choices and physical activity.
Conclusions:
- Overall satisfaction linked to structured monitoring and healthcare professional support for self-management.
- Blood glucose, physical activity, and diet data were deemed most relevant.
- Tailoring interventions to user priorities and enhancing device/structure usability can boost engagement.
- Continuous glucose monitoring integration may reduce self-monitoring burden in future interventions.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...